Mineral and bone disorders (MBD) are common in patients with chronic kidney disease
(CKD), contributing to significant morbidity and mortality. For several decades, the first-line …

Osteoporosis characterized by low bone mineral density (BMD) as assessed by dual-energy
X-ray absorptiometry (DXA) is common among end-stage renal disease (ESRD) patients …

Chronic kidney disease (CKD) is a prevalent worldwide public burden that increasingly
compromises overall health as the disease progresses. Two of the most negatively affected …

Chronic kidney disease (CKD) is commonly associated with a high burden of comorbidities
and poor clinical outcomes. Malnutrition–inflammation–atherosclerosis syndrome is …

Objective Chronic kidney disease-mineral bone disorder (CKD-MBD) is a major
complication of end-stage renal disease (ESRD). Reduced bone mineral density (BMD) is …

Background Bone disease with osteoporosis and renal osteodystrophy is common in end
stage renal disease (ESRD) patients and associates with cardiovascular disease (CVD) and …

Objectives Malnutrition occurs as a complication of hemodialysis (HD) and has been
identified as a risk factor for osteoporosis, sarcopenia, and low physical performance. The …

Although frequently silent, mineral and bone disease (MBD) is one of the most precocious
complication of chronic kidney disease (CKD) and is omnipresent in patients with CKD stage …

Bone and muscle tissue are developed hand-in-hand during childhood and adolescence
and interact through mechanical loads and biochemical pathways forming the …

Results At baseline, IGF-1 concentrations associated negatively with age, diabetes mellitus,
cardiovascular disease, poor nutritional status, IL-6, and osteoprotegerin and positively with …